Trial intelligence / Profile preview

Intravenous Magnesium for Postoperative Inflammation in Colorectal Cancer Surgery

NCT07803601Recruiting

Sponsor
Ain Shams University
Start
Mar 2026
Primary completion
Mar 2027
Countries
1
01

Overview

Randomised, double-blind trial of magnesium sulfate in post-operative inflammation and postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Postoperative White Blood Cell Count at 36 hours. Started Mar 2026; status: recruiting.

02

Drugs

magnesium sulfate
03

Conditions

post-operative inflammationpostoperative pain

Beyond the preview

Go deeper on NCT07803601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07803601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call